Lupus patients may get new hope from In-Body cell therapy
NCT ID NCT07617740
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new treatment called IASO207 for people with active lupus that hasn't responded to standard therapies. The treatment works by creating special immune cells inside the body to target and calm the overactive immune system. The study will check if it's safe and if it can reduce lupus disease activity in 18 adults aged 18-75.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, 100044, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cell shot aims to tame tough lupus cases
- Lupus patients get hope from Cancer-Fighting cell therapy
- Immune cell therapy shows promise for Tough-to-Treat lupus
- Could CAR T-Cells tame tough lupus? tiny trial aims to find out
- Immune cell therapy shows promise for tough lupus cases
- New injection aims to tame lupus when standard treatments fail